Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Identify the mistake, adjust your plan, and implement corrective habits. This concise guide gives actionable steps to recover quickly and stay on track.
18,261 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Bitcoin and Ethereum jumped after cooler-than-expected U.S. inflation data, while Japan’s Upper House committee advan...
IBM shares plunged after a softer than expected Q2 outlook, triggering a sharp one day drop. Analysts remain split, w...
The NEOS Nasdaq-100 High Income ETF (QQQI) currently yields almost 14%, drawing income seekers. But can this strategy...
In the first half of 2026, here's plug power stock surged 37.6%, signaling a renewed optimism around hydrogen fuels a...
In a world of rapid leadership shifts, Warren Buffett just reaffirmed his stance on Apple as a core holding. This art...
A leading manager weighs the case for broad crypto exposure after investors rejected crypto basket ETFs. Early demand...
A regulatory shift hit the live entertainment market, and StubHub stock plummeted this week. This deep dive explains ...
An emerging markets ETF has shown surprising strength at times. This article breaks down whether that outperformance ...
Wondering how to put $1,000 to work in AI? This guide highlights two magnificent AI stocks that pulled back and offer...
Intuitive Surgical has powered robotic surgery for years, but its stock treaded lower in 2026. This guide breaks down...
Two Vanguard growth options vie for dominance in a shifting market. This guide breaks down vanguard growth growth etf...